Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

VYNE Therapeutics (VYNE) Return on Assets (2018 - 2025)

VYNE Therapeutics (VYNE) has disclosed Return on Assets for 8 consecutive years, with 0.0% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%, compared with a TTM value of 0.0% through Dec 2025, changed 0.0%, and an annual FY2025 reading of 0.01%, up 1.0% over the prior year.
  • Return on Assets was 0.0% for Q4 2025 at VYNE Therapeutics, down from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.05% in Q2 2022 and bottomed at 1.85% in Q1 2021.
  • Average Return on Assets over 5 years is 0.21%, with a median of 0.01% recorded in 2023.
  • Peak annual rise in Return on Assets hit 215bps in 2021, while the deepest fall reached -86bps in 2021.
  • Year by year, Return on Assets stood at 0.39% in 2021, then soared by 112bps to 0.05% in 2022, then tumbled by -120bps to 0.01% in 2023, then surged by 96bps to 0.0% in 2024, then tumbled by -70bps to 0.0% in 2025.
  • Business Quant data shows Return on Assets for VYNE at 0.0% in Q4 2025, 0.0% in Q2 2025, and 0.0% in Q1 2025.